Literature DB >> 21459420

Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients.

Frank P Hurst1, Rahul M Jindal, James J Fletcher, Vikas Dharnidharka, Greg Gorman, Brent Lechner, Robert Nee, Lawrence Y Agodoa, Kevin C Abbott.   

Abstract

We carried out an analysis of the United States Renal Data System to determine the incidence, risk factors and prognosis of renal cell carcinoma (RCC) in a national population of patients receiving incident long-term dialysis. In Cox regression, male gender, older age, end-stage renal disease caused by obstruction, tuberous sclerosis, focal segmental glomerulosclerosis, as well as acquired renal cysts, were independently associated with RCC. Most cases of RCC in incident long-term dialysis patients occurred in patients without acquired renal cysts. A diagnosis of RCC was associated with increased risk of subsequent mortality overall and in all high-risk groups. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21459420     DOI: 10.1016/j.urology.2011.01.007

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.

Authors:  Anne M Butler; Andrew F Olshan; Abhijit V Kshirsagar; Jessie K Edwards; Matthew E Nielsen; Stephanie B Wheeler; M Alan Brookhart
Journal:  Am J Kidney Dis       Date:  2015-02-07       Impact factor: 8.860

2.  Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.

Authors:  Hiroki Ishihara; Hironori Fukuda; Hidekazu Tachibana; Kazuhiko Yoshida; Hirohito Kobayashi; Toshio Takagi; Junpei Iizuka; Hideki Ishida; Yoji Nagashima; Tsunenori Kondo; Kazunari Tanabe
Journal:  Clin Exp Nephrol       Date:  2021-02-27       Impact factor: 2.801

Review 3.  Epigenetic regulation in RCC: opportunities for therapeutic intervention?

Authors:  James Larkin; Xin Yi Goh; Marcus Vetter; Lisa Pickering; Charles Swanton
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

Review 4.  Risk of chronic kidney disease after cancer nephrectomy.

Authors:  Lin Li; Wei Ling Lau; Connie M Rhee; Kevin Harley; Csaba P Kovesdy; John J Sim; Steve Jacobsen; Anthony Chang; Jaime Landman; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

5.  Frequency and spectrum of metachronous malignancies in heart transplant recipients: a 11-year-experience at a German heart center.

Authors:  Thomas Strecker; Johannes Rösch; Michael Weyand; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

Review 6.  De Novo Malignancies after Kidney Transplantation.

Authors:  David Al-Adra; Talal Al-Qaoud; Kevin Fowler; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

7.  Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.

Authors:  Kathleen G Dickman; Chung-Hsin Chen; Arthur P Grollman; Yeong-Shiau Pu
Journal:  World J Urol       Date:  2022-07-22       Impact factor: 3.661

Review 8.  How simple are 'simple renal cysts'?

Authors:  Roslyn J Simms; Albert C M Ong
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

9.  Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan.

Authors:  Chi-Jung Chung; Chao-Yuan Huang; Hung-Bin Tsai; Chih-Hsin Muo; Mu-Chi Chung; Chao-Hsiang Chang; Chiu-Ching Huang
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy.

Authors:  Grzegorz Kade; Arkadiusz Lubas; Lubomir Bodnar; Cezary Szczylik; Zofia Wańkowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.